Zevia PBC
NYSE:ZVIABeverages - Non-Alcoholic
+$0.09 today
- Market cap
- $70.03M
- Beta
- 1.01
- P/E (TTM)
- -13.4
- EPS (TTM)
- -$0.10
Volume 0.26M
Average 0.89M
ZVIA Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Zevia PBCNYSE: ZVIA
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables growth accelerates
Q1 FY2026 accounts receivables of $2.03M rose 1.8% year over year, ahead of the -105.2% change in trailing-twelve-month accounts receivables. Sequentially, it rose 35.4% from the prior quarter. Over 3 fiscal years it compounded at -46.5% a year.
Context
- Accounts receivables amounted to 0.2% of revenue in FY2025, unchanged from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +1.8% holds above the trailing-twelve-month pace of -105.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (311K) USD
- Year-over-year change
- -196.0%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (311K) | -196.0% |
| FY2024 | 2024-12-31 | 324K | +871.4% |
| FY2023 | 2023-12-31 | (42K) | +97.9% |
| FY2022 | 2022-12-31 | (2.03M) | +1.6% |
| FY2021 | 2021-12-31 | (2.06M) | — |
Accounts Receivables vs competitors
How ZVIA compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -105.2% is the 6th highest of 7, against a peer median of -41.2%.
- Accounts receivables amounts to 0.2% of revenue for ZVIA, versus a peer median of 1.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | CN¥58.21M CNY | +113.9% | +56.2% | 3.1% | |
| LTM Mar 2026 | $8.53M USD | -1.9% | +10.5% | 0.7% | |
| LTM Mar 2026 | $3.67M USD | -80.6% | — | 1.2% | |
| LTM Mar 2026 | $2.29M USD | -224.1% | — | 1.1% | |
| LTM Mar 2026 | $2.19M USD | +577.8% | -5.3% | 2.4% | |
| LTM Apr 2026 | $1.69M USD | -89.3% | — | 0.3% | |
| LTM Mar 2026 | $275K USD | -105.2% | -46.5% | 0.2% | |
| Peer median (excluding ZVIA) | — | -41.2% | +10.5% | 1.2% | |
Competitors are the stored peer set for ZVIA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (87.67M) | (33.86M) | (28.32M) | (23.78M) | (9.92M) |
| Depreciation & Amortization | 997K | 2M | 1.62M | 1.33M | 868K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 77.72M | 0 | 8.28M | 4.96M | 3.76M |
| Change in Working Capital | (9.51M) | (2.08M) | 1.03M | 15.4M | 1.2M |
| Accounts Receivables | (2.06M) | (2.03M) | (42K) | 324K | (311K) |
| Inventory | (10.7M) | 3.93M | (6.97M) | 15.93M | (1.78M) |
| Accounts Payables | 4.4M | (5.85M) | 13.64M | (5.86M) | 2.01M |
| Other Working Capital | (1.15M) | 1.88M | (5.59M) | 5.01M | 1.28M |
| Other Non-Cash Items | 652K | 12.82M | 1.12M | 1.07M | (613K) |
| Operating Cash Flow | (17.81M) | (21.11M) | (16.27M) | (1.02M) | (4.7M) |
| Capital Expenditures | (3.14M) | (2.59M) | (1.62M) | (283K) | (307K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (30M) | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 30M | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 2.43M | 0 | 0 |
| Investing Cash Flow | (33.14M) | 27.41M | 805K | (283K) | (307K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 139.7M | 124K | 0 | 0 | 59K |
| Common Stock Repurchased | (49.63M) | 0 | 0 | 0 | 0 |
| Dividends Paid | (2.67M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (8.28M) | (2.13M) | 25K | 0 | (348K) |
| Financing Cash Flow | 79.12M | (2.01M) | 25K | 0 | (289K) |
| Effect of Forex Changes | 0 | (1) | 0 | 0 | 0 |
| Net Change in Cash | 28.17M | 4.29M | (15.44M) | (1.3M) | (5.3M) |
| Free Cash Flow | (20.95M) | (23.71M) | (17.9M) | (1.3M) | (5.01M) |
Zevia PBC
NYSE:ZVIA
Intrinsic Alpha fair value
Locked
Current Price
$0.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.